BIT225-012 Phase 2 COVID-19 Clinical Trial 6 September 2024 by Audrey Thomson BIT225-012 Phase 2 COVID-19 Clinical Trial
Corporate Governance Statement 2024 30 August 2024 by Audrey Thomson Corporate Governance Statement 2024
Year End Accounts and Preliminary Final Report 30 August 2024 by Audrey Thomson Year End Accounts and Preliminary Final Report
Report on Activities for the Quarter ended 30 June 2024 31 July 2024 by Audrey Thomson Report on Activities for the Quarter Ended 30 June 2024
Biotron Clinical Trial Results Webinar 25 June 2024 by Audrey Thomson Biotron Clinical Trial Results Webinar
BIT225-011 Phase 2 HIV Exploratory Efficacy Trial Meets Primary Objectives 19 June 2024 by Audrey Thomson BIT225-011 Phase 2 HIV Exploratory Efficacy Trial Meets Primary Objectives
Change of Registry Address Notification 24 May 2024 by Audrey Thomson Change of Registry Address Notification
